The 2020 Give to Cure Cancer Year-End Appeal is now underway. It’s your last chance to make this year’s campaign the most successful ever. We are proud to report… The year of 2020 turns out to be an unprecedented time of new challenge. Thanks to the stewardship of wonderful and…...
Diabetes and Cancer: What’s the Link?
Medical professionals have come to understand that diabetes, especially Type 2 diabetes, is linked to a variety of diseases. The high blood glucose from diabetes can damage the blood vessels and nerves that control the heart and blood vessels, increasing the likelihood of developing heart disease and kidney disease. However,…...
AFCR Novel Approach to the Clinical Care for Liver Cancer – 2020 Latest Update
Effective treatments are still lacking for hepatocellular carcinoma or HCC, the most common type of liver cancer and sixth most common cancer worldwide. Most patients do not survive beyond a year with current therapeutic options (surgery, liver transplantation, chemotherapy, and radiotherapy). Epigenetic factors are a key component in the development…...
Congratulations to the Finalists of the 2020 BRACE Award Venture Competition!
The Asian Fund for Cancer Research is proud to announce the top two finalists resulting from our just-concluded 2020 BRACE Award Venture Competition: Albatroz Therapeutics Scientific Founder & CEO Frederic Bard, Ph.D., and Arbele Chief Development Officer Dennis Wong, M.D. Both companies are developing innovative technologies that could lead to life-saving…...
Tasty Tomatoes: Anti-Cancer Attributes & A Healthy Recipe
While people debate the age-old question about whether tomatoes are a fruit or vegetable, here’s an undisputed fact: Tomatoes are a good source of vitamins A, C and E, and the antioxidant lycopene. Studies show that lycopene may help prevent prostate, lung, and stomach cancers. The powerful antioxidant can also help reduce your…...
Develop New Cancer Detection Tool
THE CHALLENGE —Today’s State of Cancer Detection Early detection is important because when abnormal tissue or cancer is found early, it may be easier for doctors to successfully treat their patients. Knowing the possible warning signs of cancer helps the early detection of a tumor. And screening tools can help…...
GBM AGILE New Clinical Trial Sites Being Established
In the first half of 2020, the revolutionary global clinical trial for brain cancer patients, GBM AGILE, continues to make impressive progress and achieve milestones. AFCR supported its conception in 2013 to expeditiously develop new effective treatments for GBM brain cancer patients whose five-year survival rate is currently only 5%…...